Skip to main content
. 2021 Aug 16;131(16):e138560. doi: 10.1172/JCI138560

Figure 1. Entinostat promotes a robust antitumor response in immune-competent C57BL/6 mice.

Figure 1

(A) Average BBN963 tumor volume in response to entinostat in immune-deficient NSG mice and immune-competent C57BL/6 mice with tumor volume of each individual mouse shown in separate graphs. n = 9–10 mice. (B) Average BBN966 tumor volume in response to entinostat in immune-deficient NSG mice and immune-competent C57BL/6 mice with tumor volume of each individual mouse shown in separate graphs. n = 5–6 mice. Data are represented as mean ± SD.